Efficacy and Safety of Etrasimod in Patients with Moderately to Severely Active Isolated Proctitis: Results From the Phase 3 ELEVATE UC Clinical Programme.
- DOI
- 10.1093/ecco-jcc/jjae038
- Published
- 2024 Aug 14
- Container
- Journal of Crohn's & colitis
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1093/ecco-jcc/jjae038,
title = {Efficacy and Safety of Etrasimod in Patients with Moderately to Severely Active Isolated Proctitis: Results From the Phase 3 ELEVATE UC Clinical Programme.},
author = {Peyrin-Biroulet L and Dubinsky MC and Sands BE and Panés J and Schreiber S and Reinisch W and Feagan BG and Danese S and Yarur AJ and D'Haens GR and Goetsch M and Wosik K and Keating M and Lazin K and Wu J and Modesto I and McDonnell A and Bartolome L and Vermeire S},
year = {2024},
journal = {Journal of Crohn's \& colitis},
doi = {10.1093/ecco-jcc/jjae038},
url = {https://doi.org/10.1093/ecco-jcc/jjae038}
}RIS
TY - JOUR TI - Efficacy and Safety of Etrasimod in Patients with Moderately to Severely Active Isolated Proctitis: Results From the Phase 3 ELEVATE UC Clinical Programme. AU - Peyrin-Biroulet L AU - Dubinsky MC AU - Sands BE AU - Panés J AU - Schreiber S AU - Reinisch W AU - Feagan BG AU - Danese S AU - Yarur AJ AU - D'Haens GR AU - Goetsch M AU - Wosik K AU - Keating M AU - Lazin K AU - Wu J AU - Modesto I AU - McDonnell A AU - Bartolome L AU - Vermeire S PY - 2024 JO - Journal of Crohn's & colitis DO - 10.1093/ecco-jcc/jjae038 UR - https://doi.org/10.1093/ecco-jcc/jjae038 ER -
APA
L, P., MC, D., BE, S., J, P., S, S., W, R., BG, F., S, D., AJ, Y., GR, D., M, G., K, W., M, K., K, L., J, W., I, M., A, M., L, B., & S, V. (2024). Efficacy and Safety of Etrasimod in Patients with Moderately to Severely Active Isolated Proctitis: Results From the Phase 3 ELEVATE UC Clinical Programme.. Journal of Crohn's & colitis. https://doi.org/10.1093/ecco-jcc/jjae038
Source records
- pubmed · retrieved 2026-09-26T02:40:33.872Z